Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • K Offline
    K Offline
    kkjoel
    wrote on sidst redigeret af
    #404

    Et moderne ord man ser meget er "bekymringsparat"... 😉

    1 Reply Last reply
    0
    • SolsenS Offline
      SolsenS Offline
      Solsen
      wrote on sidst redigeret af
      #405

      https://www.linkedin.com/posts/genmab_ash20-duobody-activity-6741818830106034176-KJbL Et eller andet sted skulle man kunne høre mere om epco

      1 Reply Last reply
      0
      • StockBullS Offline
        StockBullS Offline
        StockBull
        wrote on sidst redigeret af
        #406

        Morn fra BKK 🙂 Har for en ordens skyld lige checket 2020 kursstigning og ja genmab kursen er p.t steget 58% i år siden 1 Januar så personligt er jeg rimlig godt tilfreds. Kunne selvfølgelig være fedt med 100% hvert år men en gang imellem må man nøjes med 15-60%. Godt nok er Genmab en fantastisk aktie men fremadrettet tror jeg vi skal være glade for 20-30% kursstigning per år så mon ikke kurs 3000 er muligt inden udgang af 2021

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #407

          God morgen. 🙂

          1 Reply Last reply
          0
          • Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktørH Offline
            Helge_LarsenPI-redaktør
            wrote on sidst redigeret af
            #408

            God morgen. 🙂

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #409

              Tirsdagens danske avisuddrag med
              nedlukning, hjælpepakker og C25https://www.proinvestor.com/investornyt/670160/tirsdagens-danske-avisuddrag-med-nedlukning-hjaelpepakker-og-c25

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bibob
                wrote on sidst redigeret af
                #410

                OncLive. : Dr. Voorhees on updated Griffin results. https://www.onclive.com/view/dr-voorhees-on-updated-results-of-the-griffin-trial-in-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #411

                  Dara sc. https://www.onclive.com/view/subcutaneous-daratumumab-combo-improves-pfs-in-rrmm?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bibob
                    wrote on sidst redigeret af
                    #412

                    OncLive Dara combo. https://www.onclive.com/view/daratumumab-combo-improved-response-rates-for-patients-with-transplant-eligible-newly-diagnosed-multiple-myeloma?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #413

                      OncLive. Dara quadruplet. https://www.onclive.com/view/daratumumab-quadruplet-improves-hematologic-cr-rates-in-al-amyloidosis?utm_source=sfmc&utm_medium=email&utm_campaign=12-7-20_KIT-20-OGD0768_OncLiveSS_GLOBAL ASH Conference Coverage eNews_Yescarta&eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #414

                        Endpoint news: BCMA bawl: https://endpts.com/ash20-saw-a-bcma-brawl-whos-still-standing-and-who-got-knocked-out-for-good/

                        1 Reply Last reply
                        0
                        • Legolas23L Offline
                          Legolas23L Offline
                          Legolas23
                          wrote on sidst redigeret af
                          #415

                          Kan du give et kort sum-op @Sukkeralf. Det kræver medlemskab at læse artiklen.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #416

                            "I think broadly now, that we’ve seen whenever we add daratumumab to the standard of care, whatever that may be, we seem to see a significant improvement in progression-free survival and improving depth of response,” he said. https://www.hcplive.com/view/daratumumab-pomalidomide-relapsed-refractory-multiple-myeloma

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #417

                              Legolas ikke så meget nyt - artiklen mener nok at JNJ/Legends CAR-T er i førertrøjen omend de døjer med lidt neurotox. Regenron og JNJs BaAbs kommer vel ind som nummer to. Amgens BsAbs lider begge. BCMA ADC har for lav responsrate og AEs, hvor specielt ocular tox er et problem. Så ingen direkte vinder endnu....

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #418

                                Jeg har læst et sted, at Regenerons BCMA er bedre på safety end JNJs, men har ikke haft tid til at studere det nærmere.

                                1 Reply Last reply
                                0
                                • Legolas23L Offline
                                  Legolas23L Offline
                                  Legolas23
                                  wrote on sidst redigeret af
                                  #419

                                  Takker 🙂

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #420

                                    has anyone been able to see the Tahamtan Ahmadi talk & Q&A?

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      GeorgeBest
                                      wrote on sidst redigeret af
                                      #421

                                      No, I think it is only for people registered for ASH

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #422

                                        yes, but i was hoping someone here had some contacts and saw it regardless...

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #423

                                          E L I guess we will have more or less the same talk tonight

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger